{"id":865759,"date":"2025-07-01T15:05:04","date_gmt":"2025-07-01T19:05:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/saif-partners-sends-letter-to-sinovac-shareholders\/"},"modified":"2025-07-01T15:05:04","modified_gmt":"2025-07-01T19:05:04","slug":"saif-partners-sends-letter-to-sinovac-shareholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/saif-partners-sends-letter-to-sinovac-shareholders\/","title":{"rendered":"SAIF Partners Sends Letter to Sinovac Shareholders"},"content":{"rendered":"

<\/p>\n

SAIF Partners Sends Letter to Sinovac Shareholders<\/b><\/p>\n

Highlights Current Board\u2019s Empty Promises, Failure to Deliver Value for Shareholders, and Certain Directors\u2019 Concerning Patterns of Reckless, Unethical and Illegal Actions to Retain Control of Sinovac<\/i><\/p>\n

SAIF Partners Urges Shareholders to Vote the GOLD<\/span><\/b> Proxy Card \u201cFOR<\/span><\/b>\u201d its Director Nominees to End Years of Chaos, Restore Credibility and Unlock Long-Term Value for All Sinovac Shareholders<\/i><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nSAIF Partners IV L.P., (\u201cSAIF Partners\u201d), the largest single investor in Sinovac Biotech Ltd. (\u201cSinovac\u201d or the \u201cCompany\u201d), beneficially owning approximately 15% of the outstanding common shares, today sent a letter to Sinovac shareholders regarding the current Board\u2019s empty promises to shareholders, numerous failures overseeing the Company, and certain directors\u2019 concerning patterns of reckless, unethical and illegal actions to retain control of Sinovac.<\/p>\n

\nThe full text of the letter is as follows:<\/p>\n

July 1, 2025<\/b><\/p>\n

Dear Fellow Sinovac Shareholders,<\/b><\/p>\n

\nSAIF Partners (\u201cwe\u201d or \u201cus\u201d) is the largest single investor and a long-term shareholder in Sinovac Biotech Ltd. (\u201cSinovac\u201d or the \u201cCompany\u201d). We beneficially own approximately 15% of the Company\u2019s outstanding common shares. As you are likely aware, on June 24, 2025, Sinovac\u2019s Board of Directors (the \u201cBoard\u201d) announced its intention to pay \u201cup to\u201d $138.73 per share in total dividends to shareholders \u2013 a significant increase from Sinovac\u2019s previously announced $55 per share dividend scheduled to be distributed on or about July 7, 2025.<\/p>\n

As a financial investor in Sinovac just like you, we welcome the idea of the Company distributing these significant dividends.<\/b>However, we have serious doubts that the current Board will be able to deliver any further dividends to you.<\/b><\/p>\n

Don\u2019t Believe Empty Promises: Sinovac\u2019s Current Board Failed to Act Until it Was Pressured by Shareholders and Became Desperate to Win Your Votes to Retain Control of Sinovac<\/b><\/p>\n

\nShareholders should not be fooled by the current Board\u2019s empty promises intended to protect the status quo and retain their positions. Sinovac\u2019s current directors \u2013 the majority of whom were not duly elected by shareholders \u2013 have offered up such large dividends only because their positions are on the line at the upcoming Special Meeting of Shareholders (the \u201cSpecial Meeting\u201d) to be held on July 8, 2025, and they are trying to buy shareholders\u2019 support.<\/p>\n

\nFurther, the misleading dividend plan outlined by the current Board reveals its recklessness and its ignorance of the nature of Sinovac\u2019s business, the financial status of the Company, and the applicable PRC laws and regulations under which the Company operates:<\/p>\n